山莨菪碱辅助治疗儿童支原体肺炎疗效观察

被引:9
作者
高梅
徐雁冬
周永茂
机构
[1] 中山市中医院儿科
关键词
儿童; 支原体肺炎; 山莨菪碱; 穴位注射;
D O I
10.13241/j.cnki.pmb.2010.15.037
中图分类号
R725.6 [小儿呼吸系及胸部疾病];
学科分类号
100202 ;
摘要
目的:观察山莨菪碱(654-2)辅助治疗儿童支原体肺炎的临床疗效。方法:将168例支原体肺炎患儿随机分为实验组(n=90)和对照组(n=78)。实验组在以阿奇霉素静脉滴注5d基础上,合用654-2穴位注射;对照组以阿奇霉素静脉滴注5d。分析和比较两组患儿的治疗效果、不良反应等情况。结果:两组患儿在发热、咳嗽、气喘、肺部啰音等主要症状、体征消失时间比较,实验组明显短于对照组(P<0.05);实验组整体显效率(84.5%)高于对照组(64.1%)(P<0.01);两组不良反应比较,实验组不良反应发生率明显低于对照组(P<0.01)。结论:阿奇霉素联合654-2穴位注射治疗能明显改善临床症状,减少不良反应,值得临床推广应用。
引用
收藏
页码:2921 / 2923
页数:3
相关论文
共 10 条
[1]  
The pharmacological properties of anisodamine. Poupko JM,Baskin SI,Moore E. Jappl toxicol . 2007
[2]  
654-2 relieve adverse reaction of the erycin gastrointestinal tract. LIU XIAOYAN,JIN CHUN,BU XIULAN,et al. JOURNAL OF PRAC- TICAL NURSING . 1998
[3]   肺腧穴外治法治疗小儿肺炎的研究近况 [J].
李红星 ;
刘克丽 .
中医药导报, 2008, (02) :95-96+99
[4]   莨菪碱对阿奇霉素治疗肺炎患儿的影响 [J].
伍小娟 .
现代生物医学进展, 2007, (10) :1546-1547
[5]   阿奇霉素联合654-2序贯治疗小儿支原体肺炎的疗效观察 [J].
刘萍萍 .
现代医药卫生, 2007, (20) :3042-3043
[6]  
儿科临床药理学[M]. 人民卫生出版社 , 李文汉,胡仪吉主编, 1998
[7]   Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro [J].
Okazaki, N ;
Narita, M ;
Yamada, S ;
Izumikawa, K ;
Umetsu, M ;
Kenri, T ;
Sasaki, Y ;
Arakawa, Y ;
Sasaki, T .
MICROBIOLOGY AND IMMUNOLOGY, 2001, 45 (08) :617-620
[8]  
Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Okazaki N, Narita M, Yamadas, et al. Microbiology and Immunology . 2001
[9]  
Mycoplasma pneumoniae and its role as a human pathogen. Waites KB, Talkington DF. Clinical Microbiology Reviews . 2004
[10]  
Infection by Mycoplasma pneumoniae and its importance as an etio-logical agent in childhood community acquired pneumo-nias. Vervloet LA,Marguet C,Camargos PA. Brazilian Journal of Infectious Diseases . 2007